Compare RFIL & NAII Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RFIL | NAII |
|---|---|---|
| Founded | 1979 | 1980 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Electrical Products | Medicinal Chemicals and Botanical Products |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 99.5M | 16.9M |
| IPO Year | 1996 | 1995 |
| Metric | RFIL | NAII |
|---|---|---|
| Price | $13.04 | $2.65 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $9.25 | N/A |
| AVG Volume (30 Days) | ★ 228.5K | 18.4K |
| Earning Date | 06-22-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 101.59 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $55,325,000.00 | ★ $132,437,000.00 |
| Revenue This Year | $7.07 | N/A |
| Revenue Next Year | $5.72 | N/A |
| P/E Ratio | $1,203.00 | ★ N/A |
| Revenue Growth | ★ 10.22 | 8.60 |
| 52 Week Low | $3.39 | $2.33 |
| 52 Week High | $13.09 | $4.96 |
| Indicator | RFIL | NAII |
|---|---|---|
| Relative Strength Index (RSI) | 61.97 | 36.35 |
| Support Level | $6.32 | $2.60 |
| Resistance Level | N/A | $2.89 |
| Average True Range (ATR) | 1.29 | 0.11 |
| MACD | 0.03 | 0.03 |
| Stochastic Oscillator | 87.37 | 12.50 |
RF Industries Ltd is engaged in the design, manufacture, and marketing of interconnect products and systems, including coaxial and specialty cables, fiber optic cables and connectors, and electrical and electronic specialty cables. The company has one operating segment. The company operates in Canada, Germany, China, the USA, and the United Kingdom, and Others.
Natural Alternatives International Inc is engaged in formulating, manufacturing, and marketing nutritional supplements. It offers vitamins, minerals, herbs, and other supplements, as well as other healthcare products, to customers within the United States and internationally. Its business activity is operated through Private-Label Contract Manufacturing and Patent & Trademark Licensing segments. The company derives the majority of revenue from Private-Label Contract Manufacturing, which is engaged in providing manufacturing services to companies that market and distribute nutritional supplements and other healthcare products, whereas the Patent and Trademark Licensing segment includes royalty income from its license and supply agreements associated with the sale.